Process Development Engineer I
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Process Development Engineer I to join our Bioreactor and Scale-Up Development Group within Preclinical Manufacturing and Process Development (PMPD), supporting early-stage biologics development in an on-site work model. In this role, you will help develop clinically enabling manufacturing processes at pilot scale in a non-GMP laboratory, while collaborating with process development and technology transfer teams.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Process Development Engineer I to join our Bioreactor and Scale-Up Development Group within Preclinical Manufacturing and Process Development (PMPD), supporting early-stage biologics development in an on-site work model. In this role, you will help develop clinically enabling manufacturing processes at pilot scale in a non-GMP laboratory, while collaborating with process development and technology transfer teams.
Discover your role
- Support lab operations to cultivate mammalian cells producing biologics in bench and pilot-scale bioreactors
- Prepare, sterilize, and operate bioreactors, and prepare buffers and feeds
- Maintain and onboard laboratory equipment to keep the lab safe, effective, and efficient
- Contribute to technology development projects, including areas of your own interest
- Evaluate and solve challenges associated with process scale-up
- Analyze seed train, production, and quality data to support process understanding and technology transfer
- Author development reports, process transmittals, and electronic notebook documentation
- Support Technology Transfer Start-Up Teams, virtually and on-site, during clinical production campaigns
This role requires
- Chemical Engineering or Bio-related Engineering degree (BS) or (MS) with 0–2 years of laboratory experience
- Strong initiative and drive to complete bold tasks and learn new technologies
- Strong communication skills, including analytical, computer, and technical writing skills
- Comfortable managing multiple projects at the same time, work well both independently and as part of a team
- Preferred: experience with bench-top and single-use bioreactors (NOVA FLEX, Sartorius Biostat DCU, Applikon, WAVE, ABEC/Hyclone 50–500L), ABEC stainless steel pilot-scale bioreactors (40–500L), and perfusion or continuous processing
- Preferred: experience with supporting equipment and systems (medium prep skid, CIP, biosafety cabinets, incubators, autoclave)
- Preferred: experience with software tools (Biobrain Operate, SynTQ, PI Historian, JMP, Benchling, Ignition)
Requirements
- Chemical Engineering or Bio-related Engineering degree (BS) or (MS)
- 0–2 years of laboratory experience
- Strong initiative and drive to complete bold tasks and learn new technologies
- Strong communication skills, including analytical, computer, and technical writing skills
- Comfortable managing multiple projects at the same time
- Work well both independently and as part of a team
- Preferred: experience with bench-top and single-use bioreactors (NOVA FLEX, Sartorius Biostat DCU, Applikon, WAVE, ABEC/Hyclone 50–500L)
- Preferred: experience with ABEC stainless steel pilot-scale bioreactors (40–500L)
- Preferred: experience with perfusion or continuous processing
- Preferred: experience with supporting equipment and systems (medium prep skid, CIP, biosafety cabinets, incubators, autoclave)
- Preferred: experience with software tools (Biobrain Operate, SynTQ, PI Historian, JMP, Benchling, Ignition)
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.